These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30221835)

  • 1. Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid Arthritis.
    Liu L; Guo W; Liang XJ
    Biotechnol J; 2019 Jan; 14(1):e1800024. PubMed ID: 30221835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine - advantages for their use in rheumatoid arthritis theranostics.
    Xiao S; Tang Y; Lv Z; Lin Y; Chen L
    J Control Release; 2019 Dec; 316():302-316. PubMed ID: 31715278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.
    Liu L; Hu F; Wang H; Wu X; Eltahan AS; Stanford S; Bottini N; Xiao H; Bottini M; Guo W; Liang XJ
    ACS Nano; 2019 May; 13(5):5036-5048. PubMed ID: 30978282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology-Activated Ultrasensitive Nanomedicines for Precise NIR-II FL/MRI Imaging-Guided "Knock-On" Dynamic Therapy in Rheumatoid Arthritis.
    Dai R; Zhao M; Zheng X; Li D; Kang W; Hao H; Chen X; Jin Y; Li J; Liu Q; Zheng Z; Zhang R
    Adv Healthc Mater; 2024 Apr; 13(11):e2303892. PubMed ID: 38219028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
    Han Y; Huang S
    J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.
    Ren S; Xu Y; Dong X; Mu Q; Chen X; Yu Y; Su G
    J Nanobiotechnology; 2024 Jul; 22(1):431. PubMed ID: 39034407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: Multi-functionalization as an emerging strategy to optimize therapeutic efficacy.
    Fang G; Zhang Q; Pang Y; Thu HE; Hussain Z
    J Control Release; 2019 Jun; 303():181-208. PubMed ID: 31015032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-Based Nanomedicine Therapeutics for Rheumatoid Arthritis.
    Rahman M; Beg S; Anwar F; Kumar V; Ubale R; Addo RT; Ali R; Akhter S
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):283-316. PubMed ID: 29199587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in nanomedicines for the treatment of rheumatoid arthritis.
    Wang Q; Sun X
    Biomater Sci; 2017 Jul; 5(8):1407-1420. PubMed ID: 28631779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis.
    Rahman M; Beg S; Sharma G; Saini S; Rub RA; Aneja P; Anwar F; Alam MA; Kumar V
    Recent Pat Antiinfect Drug Discov; 2016; 11(1):3-15. PubMed ID: 27193030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.
    Xu XL; Lu KJ; Yao XQ; Ying XY; Du YZ
    Curr Pharm Des; 2019; 25(2):155-165. PubMed ID: 30907308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment.
    Deng Y; Zheng H; Li B; Huang F; Qiu Y; Yang Y; Sheng W; Peng C; Tian X; Wang W; Yu H
    J Control Release; 2024 Jul; 371():498-515. PubMed ID: 38849090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis.
    Singh R; Jadhav K; Vaghasiya K; Ray E; Shukla R; Verma RK
    Curr Pharm Des; 2023; 29(13):984-1001. PubMed ID: 37038685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
    Pirmardvand Chegini S; Varshosaz J; Taymouri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology as a promising platform for rheumatoid arthritis management: Diagnosis, treatment, and treatment monitoring.
    Rahimizadeh P; Rezaieyazdi Z; Behzadi F; Hajizade A; Lim SI
    Int J Pharm; 2021 Nov; 609():121137. PubMed ID: 34592396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine targeted anti-inflammatory therapy to deal with the 'crux' of rheumatoid arthritis.
    An M; Zhang J; Zhang X; Zhao Y; Liu Y
    J Drug Target; 2024 Apr; 32(4):381-392. PubMed ID: 38321981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.
    Nautiyal G; Sharma SK; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2024; 18(4):433-456. PubMed ID: 37904559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of nanoparticle technology in rheumatoid arthritis treatment.
    Dolati S; Sadreddini S; Rostamzadeh D; Ahmadi M; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2016 May; 80():30-41. PubMed ID: 27133037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis.
    Shen Q; Du Y
    Int J Pharm; 2023 Mar; 635():122698. PubMed ID: 36754181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy.
    Xie Y; Tuguntaev RG; Mao C; Chen H; Tao Y; Wang S; Yang B; Guo W
    Biophys Rep; 2020 Oct; 6(5):193-210. PubMed ID: 37288306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.